Capital Performance Advisors LLP Zoetis Inc. Transaction History
Capital Performance Advisors LLP
- $597 Million
- Q3 2025
A detailed history of Capital Performance Advisors LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 1,607 shares of ZTS stock, worth $234,766. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,607
Previous 1,678
4.23%
Holding current value
$234,766
Previous $261,000
9.96%
% of portfolio
0.04%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding ZTS
# of Institutions
2,120Shares Held
430MCall Options Held
1.47MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA41.9MShares$6.12 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$2.88 Billion0.12% of portfolio
-
Morgan Stanley New York, NY17.7MShares$2.59 Billion0.19% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.32 Billion2.21% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $68.4B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...